These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 16882706)

  • 21. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice.
    Bartnikas TB; Andrews NC; Fleming MD
    Blood; 2011 Jan; 117(2):630-7. PubMed ID: 20956801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepcidin expression in patients with acute leukaemia.
    Cheng PP; Sun ZZ; Jiang F; Tang YT; Jiao XY
    Eur J Clin Invest; 2012 May; 42(5):517-25. PubMed ID: 22023453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An update on iron physiology.
    Muñoz M; Villar I; García-Erce JA
    World J Gastroenterol; 2009 Oct; 15(37):4617-26. PubMed ID: 19787824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepcidin and disorders of iron metabolism.
    Ganz T; Nemeth E
    Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice.
    Díaz V; Gammella E; Recalcati S; Santambrogio P; Naldi AM; Vogel J; Gassmann M; Cairo G
    Hepatology; 2013 Dec; 58(6):2122-32. PubMed ID: 23744538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid anemia.
    Masson C
    Joint Bone Spine; 2011 Mar; 78(2):131-7. PubMed ID: 20851655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist.
    Atkinson MA; White CT
    Pediatr Nephrol; 2012 Jan; 27(1):33-40. PubMed ID: 21400189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha.
    Pinto JP; Ribeiro S; Pontes H; Thowfeequ S; Tosh D; Carvalho F; Porto G
    Blood; 2008 Jun; 111(12):5727-33. PubMed ID: 18326822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice.
    Sasaki Y; Noguchi-Sasaki M; Yasuno H; Yorozu K; Shimonaka Y
    Int J Hematol; 2012 Dec; 96(6):692-700. PubMed ID: 23160767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
    Jain M; Joharapurkar A; Patel V; Kshirsagar S; Sutariya B; Patel M; Patel H; Patel PR
    Eur J Pharmacol; 2019 Jan; 843():113-120. PubMed ID: 30458168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron regulation and erythropoiesis.
    Nemeth E
    Curr Opin Hematol; 2008 May; 15(3):169-75. PubMed ID: 18391780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia.
    Rivera S; Liu L; Nemeth E; Gabayan V; Sorensen OE; Ganz T
    Blood; 2005 Feb; 105(4):1797-802. PubMed ID: 15479721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal inflammation modulates expression of the iron-regulating hormone hepcidin depending on erythropoietic activity and the commensal microbiota.
    Shanmugam NK; Trebicka E; Fu LL; Shi HN; Cherayil BJ
    J Immunol; 2014 Aug; 193(3):1398-407. PubMed ID: 24973448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary hepcidin in congenital chronic anemias.
    Kearney SL; Nemeth E; Neufeld EJ; Thapa D; Ganz T; Weinstein DA; Cunningham MJ
    Pediatr Blood Cancer; 2007 Jan; 48(1):57-63. PubMed ID: 16220548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythropoietic regulators of iron metabolism.
    Ganz T
    Free Radic Biol Med; 2019 Mar; 133():69-74. PubMed ID: 29981834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancements in anemias related to chronic conditions.
    Guidi GC; Lechi Santonastaso C
    Clin Chem Lab Med; 2010 Sep; 48(9):1217-26. PubMed ID: 20618092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
    Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
    Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.
    Zaritsky J; Young B; Gales B; Wang HJ; Rastogi A; Westerman M; Nemeth E; Ganz T; Salusky IB
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1010-4. PubMed ID: 20299375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepcidin in beta-thalassemia.
    Nemeth E
    Ann N Y Acad Sci; 2010 Aug; 1202():31-5. PubMed ID: 20712769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?
    Nakanishi T; Kuragano T; Kaibe S; Nagasawa Y; Hasuike Y
    Clin Exp Nephrol; 2012 Dec; 16(6):819-26. PubMed ID: 23053592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.